Botanical species · safety record

Curcuma phaeocaulis

The EFSA Compendium of Botanicals holds 5 constituent measurements for Curcuma phaeocaulis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Curcuma phaeocaulis Valeton

5Constituent measurements

0Safety records

3Cited sources

39Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 39 licensed products naming Curcuma phaeocaulis as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Curcuma phaeocaulis Rhizome
Rhizome
Rhizome (Processed with vinegar)
Rhizome(s)

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Curcumin	Roots and other underground parts	Solvent extraction	≤ 0.098 Milligram/gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Curcumin	Roots and other underground parts	Solvent extraction	≥ 0.03 Milligram/gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Furanodienone	Roots and other underground parts	Solvent extraction	≥ 3.71 Milligram/gram	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Furanodienone	Roots and other underground parts	Solvent extraction	≤ 5.84 Milligram/gram	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Sesquiterpene alkaloids	Roots and other underground parts	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Li, Rui., Xiang, Cheng., Ye, Min., Li, Hui-Fang., Zhang, Xing., Guo, De-An. Qualitative and quantitative analysis of curcuminoids in herbal medicines derived from Curcuma species . Food chemistry, 2011, vol. 126, no. 4, p. 1890-1895. DOI
Zhang, J. S., Guan, J., Yang, F. Q., Liu, H. G., Cheng, X. J., Li, S. P. Qualitative and quantitative analysis of four species of Curcuma rhizomes using twice development thin layer chromatography . Journal of pharmaceutical and biomedical analysis, 2008, vol. 48, no. 3, p. 1024-1028. DOI
Xia Gui-Yang., Owusu Donkor Paul., Ding Li-Qin., Qiu Feng., Xia Gui-Yang., Sun De-Juan., Ma Jiang-Hao., Liu Yue., Chen Li-Xia., Zhao Feng. (+)/(-)-Phaeocaulin A-D, four pairs of new enantiomeric germacrane-type sesquiterpenes from Curcuma phaeocaulis as natural nitric oxide inhibitors. Scientific reports, 2017, vol. 7, p. 43576.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature